Composition for enhancing the efficacy of antibody drugs – Japan Patent No. 7088502 Patent Details Country of RegistrationJapan Patent No.No. 7088502Registration DateJune 13, 2022 This patent is for the combination of “antibody drugs” such as immune checkpoint inhibitors and β-glucan to enhance their effects.